Arbutus Biopharma Files 8-K
Ticker: ABUS · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, financial-reporting
TL;DR
Arbutus Biopharma filed an 8-K on April 23, 2025, with corporate updates.
AI Summary
Arbutus Biopharma Corporation filed an 8-K on April 23, 2025, reporting on other events and financial statements. The company, formerly known as Tekmira Pharmaceuticals Corp, is incorporated in British Columbia, Canada, and its principal executive offices are located in Warminster, Pennsylvania.
Why It Matters
This filing provides official updates on Arbutus Biopharma's corporate activities and financial reporting, which are crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing for corporate and financial updates, not indicating any immediate significant operational or financial changes.
Key Players & Entities
- Arbutus Biopharma Corporation (company) — Registrant
- Tekmira Pharmaceuticals Corp (company) — Former company name
- April 23, 2025 (date) — Date of report
- Warminster, Pennsylvania (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of April 23, 2025.
What was Arbutus Biopharma Corporation's former name?
Arbutus Biopharma Corporation was formerly known as Tekmira Pharmaceuticals Corp.
In which jurisdiction is Arbutus Biopharma Corporation incorporated?
Arbutus Biopharma Corporation is incorporated in British Columbia, Canada.
What is the address of Arbutus Biopharma Corporation's principal executive offices?
The principal executive offices of Arbutus Biopharma Corporation are located at 701 Veterans Circle, Warminster, Pennsylvania 18974.
What is the SEC file number for Arbutus Biopharma Corporation?
The SEC file number for Arbutus Biopharma Corporation is 001-34949.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Arbutus Biopharma Corp (ABUS).